Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Veradermics has the lowest figure of the 61 pharmaceutical companies ranked by cash on hand, at ZAR 376.6M, followed by Oruka Therapeutics (ZAR 812.2M) and Dianthus Therapeutics (ZAR 884M). Figures as of 19 Nov 2026, 02:09 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- VeradermicsZAR 376.6M
- Median
- ZAR 9.9B
- Combined market value
- ZAR 87.54T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | ZAR 376.6M | ZAR 91.2B | ZAR 2,160.59 | 0.62% down | 233% up | ||
| 2 | Oruka TherapeuticsORKA · Health Care | ZAR 812.2M | ZAR 112.4B | ZAR 1,656.69 | 0.60% down | 241% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | ZAR 884M | ZAR 81.8B | ZAR 1,453.20 | 3.45% down | 113% up | ||
| 4 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 939.6M | ZAR 142.8B | ZAR 2,059.88 | 2.08% up | 13% up | ||
| 5 | Edgewise TherapeuticsEWTX · Health Care | ZAR 1.1B | ZAR 78.4B | ZAR 715.87 | 1.59% down | 88% up | ||
| 6 | ErascaERAS · Health Care | ZAR 1.3B | ZAR 83.6B | ZAR 238.10 | 0.94% down | 403% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | ZAR 1.4B | ZAR 172.9B | ZAR 1,144.15 | 5.44% up | 107% up | ||
| 8 | Spyre TherapeuticsSYRE · Health Care | ZAR 1.5B | ZAR 166.7B | ZAR 1,755.67 | 8.15% up | 286% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | ZAR 1.6B | ZAR 83.5B | ZAR 869.36 | 1.68% down | 44% up | ||
| 10 | Corcept TherapeuticsCORT · Health Care | ZAR 2.1B | ZAR 128.4B | ZAR 1,173.04 | 3.25% down | 8% down | ||
| 11 | CytokineticsCYTK · Health Care | ZAR 2.1B | ZAR 123.7B | ZAR 888.05 | 0.64% down | 20% down | ||
| 12 | Protagonist TherapeuticsPTGX · Health Care | ZAR 2.2B | ZAR 143.6B | ZAR 2,200.39 | 2.00% up | 46% up | ||
| 13 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 2.8B | ZAR 216.1B | ZAR 259.22 | 1.28% up | 5% up | ||
| 14 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 2.9B | ZAR 129.2B | ZAR 1,644.75 | 0.06% down | 126% up | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | ZAR 3B | ZAR 103.4B | ZAR 5,168.91 | 1.67% up | 43% up | ||
| 16 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 3.4B | ZAR 160B | ZAR 6,888.42 | 5.67% down | 24% down | ||
| 17 | Summit TherapeuticsSMMT · Health Care | ZAR 3.9B | ZAR 145.3B | ZAR 181.69 | 1.59% down | 36% down | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 3.9B | ZAR 105.5B | ZAR 745.98 | 0.28% up | 10% up | ||
| 19 | Definium TherapeuticsDFTX · Health Care | ZAR 4.5B | ZAR 69B | ZAR 503.90 | 0.88% down | 169% up | ||
| 20 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 4.9B | ZAR 131.9B | ZAR 378.61 | 3.60% up | 83% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 5.1B | ZAR 104.5B | ZAR 1,600.46 | 0.59% up | 31% up | ||
| 22 | Cogent BiosciencesCOGT · Health Care | ZAR 5.4B | ZAR 83.7B | ZAR 481.23 | 0.14% down | 20% down | ||
| 23 | Axsome TherapeuticsAXSM · Health Care | ZAR 5.6B | ZAR 122B | ZAR 2,318.75 | 1.43% down | 7% down | ||
| 24 | Belite BioBLTE · Health Care | ZAR 6.1B | ZAR 109.8B | ZAR 2,703.42 | 0.94% down | 31% up | ||
| 25 | Praxis Precision MedicinesPRAX · Health Care | ZAR 6.2B | ZAR 147.6B | ZAR 5,281.04 | 0.04% up | 61% up | ||
| 26 | Ionis PharmaceuticalsIONS · Health Care | ZAR 6.4B | ZAR 78.9B | ZAR 473.96 | 1.59% up | 64% down | ||
| 27 | AlkermesALKS · Health Care | ZAR 6.7B | ZAR 136.2B | ZAR 810.70 | 3.08% up | 58% up | ||
| 28 | InsmedINSM · Health Care | ZAR 8.8B | ZAR 454.8B | ZAR 2,073.03 | 1.69% down | 40% down | ||
| 29 | Elanco Animal HealthELAN · Health Care | ZAR 9.4B | ZAR 230.9B | ZAR 462.02 | 3.29% up | 20% up | ||
| 30 | BridgeBio PharmaBBIO · Health Care | ZAR 9.9B | ZAR 263B | ZAR 1,349.89 | 1.58% up | 17% up | ||
| 31 | ABIVAXABVX · Health Care | ZAR 9.9B | ZAR 127B | ZAR 1,450.60 | 2.11% up | 27% down | ||
| 32 | Royalty PharmaRPRX · Health Care | ZAR 10.7B | ZAR 683.2B | ZAR 1,188.27 | 0.01% down | 78% up | ||
| 33 | Ascendis PharmaASND · Health Care | ZAR 11.8B | ZAR 306.8B | ZAR 4,677.82 | 0.32% down | 28% up | ||
| 34 | Legend BiotechLEGN · Health Care | ZAR 15.6B | ZAR 54.5B | ZAR 281.19 | 0.87% up | 42% down | ||
| 35 | GrifolsGRFS · Health Care | ZAR 15.8B | ZAR 99.7B | ZAR 146.57 | 1.85% down | 1% up | ||
| 36 | PTC TherapeuticsPTCT · Health Care | ZAR 17B | ZAR 87.1B | ZAR 1,042.23 | 0.22% down | 20% down | ||
| 37 | PfizerPFE · Health Care | ZAR 19.8B | ZAR 2.77T | ZAR 485.55 | 1.44% down | 14% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 22.7B | ZAR 205.9B | ZAR 1,062.99 | 4.99% up | 11% up | ||
| 39 | ViatrisVTRS · Health Care | ZAR 22.9B | ZAR 402.3B | ZAR 350.93 | 0.83% down | 96% up | ||
| 40 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 24.1B | ZAR 275.2B | ZAR 4,287.44 | 2.93% up | 37% up | ||
| 41 | Roivant SciencesROIV · Health Care | ZAR 24.6B | ZAR 485.6B | ZAR 670.19 | 0.05% up | 90% up | ||
| 42 | United TherapeuticsUTHR · Health Care | ZAR 26.9B | ZAR 425.5B | ZAR 9,990.35 | 1.16% down | 23% up | ||
| 43 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 28.7B | ZAR 346.3B | ZAR 2,585.23 | 4.54% down | 66% down | ||
| 44 | GenmabGMAB · Health Care | ZAR 29.7B | ZAR 543.8B | ZAR 881.99 | 1.91% down | 70% up | ||
| 45 | ZoetisZTS · Health Care | ZAR 40B | ZAR 601.6B | ZAR 1,480.71 | 2.50% up | 29% down | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 54B | ZAR 1.69T | ZAR 16,361.55 | 1.28% down | 36% up | ||
| 47 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 61.5B | ZAR 852.7B | ZAR 730.75 | 0.92% down | 74% up | ||
| 48 | Takeda PharmaceuticalTAK · Health Care | ZAR 64.5B | ZAR 1.18T | ZAR 368.06 | 1.71% down | 54% up | ||
| 49 | Novo NordiskNVO · Health Care | ZAR 68B | ZAR 3.01T | ZAR 682.30 | 3.12% down | 17% down | ||
| 50 | GSKGSK · Health Care | ZAR 78B | ZAR 1.69T | ZAR 840.63 | 1.34% down | 6% up | ||
| 51 | BeOne MedicinesONC · Health Care | ZAR 78.7B | ZAR 797.7B | ZAR 6,983.93 | 2.34% down | 17% up | ||
| 52 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 88B | ZAR 2.35T | ZAR 9,282.78 | 0.42% up | 27% up | ||
| 53 | AbbVieABBV · Health Care | ZAR 90.5B | ZAR 8.75T | ZAR 4,949.15 | 2.33% down | 26% up | ||
| 54 | AstraZenecaAZN · Health Care | ZAR 98.8B | ZAR 4.8T | ZAR 3,093.28 | 1.93% down | 2% up | ||
| 55 | Eli LillyLLY · Health Care | ZAR 125.8B | ZAR 21.31T | ZAR 23,927.24 | 2.32% down | 35% up | ||
| 56 | SanofiSNY · Health Care | ZAR 147B | ZAR 1.96T | ZAR 815.37 | 0.86% down | 4% down | ||
| 57 | Abbott LaboratoriesABT · Health Care | ZAR 147.5B | ZAR 3.13T | ZAR 1,807.93 | 0.22% down | 17% down | ||
| 58 | Bristol-Myers SquibbBMY · Health Care | ZAR 176.7B | ZAR 2.11T | ZAR 1,030.63 | 2.92% down | 34% up | ||
| 59 | NovartisNVS · Health Care | ZAR 197.9B | ZAR 5.07T | ZAR 2,685.77 | 2.46% down | 25% up | ||
| 60 | Merck & CoMRK · Health Care | ZAR 252B | ZAR 5.88T | ZAR 2,384.16 | 3.90% down | 51% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | ZAR 341B | ZAR 11.36T | ZAR 4,718.83 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.3041 ZAR).
Questions and answers
Which pharmaceutical companies have the lowest cash on hand?
Veradermics (ZAR 376.6M), Oruka Therapeutics (ZAR 812.2M) and Dianthus Therapeutics (ZAR 884M) have the lowest cash on hand of the 61 pharmaceutical companies ranked here as of 19 Nov 2026, 02:09 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of ZAR 87.54T as of 19 Nov 2026, 02:09 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.